These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 37189632)

  • 1. Intestinal Damage, Inflammation and Microbiota Alteration during COVID-19 Infection.
    Saviano A; Brigida M; Petruzziello C; Zanza C; Candelli M; Morabito Loprete MR; Saleem F; Ojetti V
    Biomedicines; 2023 Mar; 11(4):. PubMed ID: 37189632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19.
    Jin B; Singh R; Ha SE; Zogg H; Park PJ; Ro S
    World J Gastroenterol; 2021 May; 27(19):2341-2352. PubMed ID: 34040326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal Damage in COVID-19: SARS-CoV-2 Infection and Intestinal Thrombosis.
    Wu X; Jing H; Wang C; Wang Y; Zuo N; Jiang T; Novakovic VA; Shi J
    Front Microbiol; 2022; 13():860931. PubMed ID: 35391725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatology and microbiology of the gastrointestinal tract in post-COVID conditions.
    Norouzi Masir M; Shirvaliloo M
    JGH Open; 2022 Aug; 6(10):667-76. PubMed ID: 36247234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herbal Medicine, Gut Microbiota, and COVID-19.
    Chen Z; Lv Y; Xu H; Deng L
    Front Pharmacol; 2021; 12():646560. PubMed ID: 34305582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19.
    Zhang J; Garrett S; Sun J
    Genes Dis; 2021 Jul; 8(4):385-400. PubMed ID: 33521210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of SARS-CoV-2 infection for neurogastroenterology.
    Marasco G; Lenti MV; Cremon C; Barbaro MR; Stanghellini V; Di Sabatino A; Barbara G
    Neurogastroenterol Motil; 2021 Mar; 33(3):e14104. PubMed ID: 33591607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of COVID-19 on the Gut: A Review of the Manifestations, Pathology, Management, and Challenges.
    Suryana KD; Simadibrata M; Renaldi K
    Acta Med Indones; 2021 Jan; 53(1):96-104. PubMed ID: 33818412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters.
    Sencio V; Machelart A; Robil C; Benech N; Hoffmann E; Galbert C; Deryuter L; Heumel S; Hantute-Ghesquier A; Flourens A; Brodin P; Infanti F; Richard V; Dubuisson J; Grangette C; Sulpice T; Wolowczuk I; Pinet F; Prévot V; Belouzard S; Briand F; Duterque-Coquillaud M; Sokol H; Trottein F
    Gut Microbes; 2022; 14(1):2018900. PubMed ID: 34965194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - Role of gut microbiota dysbiosis.
    Viana SD; Nunes S; Reis F
    Ageing Res Rev; 2020 Sep; 62():101123. PubMed ID: 32683039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
    Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
    Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19, nausea, and vomiting.
    Andrews PLR; Cai W; Rudd JA; Sanger GJ
    J Gastroenterol Hepatol; 2021 Mar; 36(3):646-656. PubMed ID: 32955126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Main Clinical Features of COVID-19 and Potential Prognostic and Therapeutic Value of the Microbiota in SARS-CoV-2 Infections.
    He Y; Wang J; Li F; Shi Y
    Front Microbiol; 2020; 11():1302. PubMed ID: 32582134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diet, Probiotics and Their Impact on the Gut Microbiota during the COVID-19 Pandemic.
    Jabczyk M; Nowak J; Hudzik B; Zubelewicz-Szkodzińska B
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route.
    de Oliveira AP; Lopes ALF; Pacheco G; de Sá Guimarães Nolêto IR; Nicolau LAD; Medeiros JVR
    Med Hypotheses; 2020 Nov; 144():110243. PubMed ID: 33254549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traditional Chinese medicine against COVID-19: Role of the gut microbiota.
    Yang Z; Liu Y; Wang L; Lin S; Dai X; Yan H; Ge Z; Ren Q; Wang H; Zhu F; Wang S
    Biomed Pharmacother; 2022 May; 149():112787. PubMed ID: 35279010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 - gastrointestinal and gut microbiota-related aspects.
    Kaźmierczak-Siedlecka K; Vitale E; Makarewicz W
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10853-10859. PubMed ID: 33155247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.
    Nascimento Conde J; Schutt WR; Gorbunova EE; Mackow ER
    mBio; 2020 Dec; 11(6):. PubMed ID: 33310781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and Gastrointestinal Tract: From Pathophysiology to Clinical Manifestations.
    Vernia F; Ashktorab H; Cesaro N; Monaco S; Faenza S; Sgamma E; Viscido A; Latella G
    Medicina (Kaunas); 2023 Sep; 59(10):. PubMed ID: 37893427
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathogenesis and Mechanism of Gastrointestinal Infection With COVID-19.
    Zhang H; Shao B; Dang Q; Chen Z; Zhou Q; Luo H; Yuan W; Sun Z
    Front Immunol; 2021; 12():674074. PubMed ID: 34858386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.